AI Portfolio Summary
In 2025 Q4, First Turn Management, LLC maintained a portfolio of 41 distinct positions. The most significant new addition to the portfolio was TERNS PHARMACEUTICAL, which now represents 4.03% of the total fund value. They heavily accumulated shares in ABIVAX SA, increasing their position by 30.6%. Conversely, First Turn Management, LLC completely exited their position in HARROW INC.
Total Positions
41
Quarter
2025 Q4
Top Holding
ABVX (5.9%)
Top 10 Concentration
47.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-41 of 41
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABVX
ABIVAX SA
|
Healthcare | 5.87% | 3.72% |
#1
14
Prev: #15
|
6.8 | 89,413 | 30.6% |
P
S
|
381,233 | $51,411,176 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 5.81% | 4.51% |
#2
6
Prev: #8
|
4.3 | -4,665 | -0.7% |
P
S
|
638,385 | $50,847,365 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 5.26% | 6.91% |
#3
2
Prev: #1
|
3.6 | -55,480 | -17.3% |
P
S
|
264,293 | $45,997,554 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 5.20% | 4.60% |
#4
3
Prev: #7
|
3.1 | 5,744 | 1.0% |
P
S
|
595,473 | $45,547,730 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 4.35% | 6.28% |
#5
3
Prev: #2
|
2.7 | -89,005 | -15.6% |
P
S
|
481,564 | $38,038,740 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 4.32% | 2.78% |
#6
12
Prev: #18
|
4.2 | 54,307 | 35.6% |
P
S
|
206,921 | $37,792,051 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVL
NUVALENT INC
|
Healthcare | 4.24% | 5.13% |
#7
2
Prev: #5
|
2.2 | -26,057 | -6.6% |
P
S
|
368,697 | $37,087,231 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 4.10% | 4.82% |
#8
2
Prev: #6
|
2.6 | no change | no change |
P
S
|
799,743 | $35,844,481 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 4.10% | 2.40% |
#9
11
Prev: #20
|
3.6 | 72,028 | 17.9% |
P
S
|
474,839 | $35,840,848 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 4.03% | — |
#10
Prev: #—
|
5.1 | 872,049 | no change |
NEW
|
872,049 | $35,230,780 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 3.58% | 3.06% |
#11
5
Prev: #16
|
3.9 | 176,502 | 24.6% |
P
S
|
893,473 | $31,343,033 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 3.54% | 5.37% |
#12
9
Prev: #3
|
1.4 | -21,738 | -25.5% |
P
S
|
63,580 | $30,979,355 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 3.48% | 1.55% |
#13
14
Prev: #27
|
4.4 | 247,245 | 69.7% |
P
S
|
601,774 | $30,473,835 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 3.35% | — |
#14
Prev: #—
|
4.8 | 824,283 | no change |
NEW
|
824,283 | $29,278,532 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 3.21% | 4.37% |
#15
6
Prev: #9
|
1.8 | -14,483 | -9.9% |
P
S
|
131,808 | $28,106,738 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 3.17% | — |
#16
Prev: #—
|
4.8 | 271,685 | no change |
NEW
|
271,685 | $27,749,906 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 2.94% | 2.18% |
#17
6
Prev: #23
|
3.7 | 227,114 | 23.7% |
P
S
|
1,186,817 | $25,753,929 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 2.86% | — |
#18
Prev: #—
|
4.6 | 723,653 | no change |
NEW
|
723,653 | $25,016,684 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 2.46% | — |
#19
Prev: #—
|
4.5 | 690,528 | no change |
NEW
|
690,528 | $21,489,231 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 2.45% | — |
#20
Prev: #—
|
4.5 | 1,892,683 | no change |
NEW
|
1,892,683 | $21,406,245 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 2.36% | 2.10% |
#21
3
Prev: #24
|
3.4 | 70,873 | 27.8% |
P
S
|
325,668 | $20,692,945 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 2.31% | — |
#22
Prev: #—
|
4.4 | 459,727 | no change |
NEW
|
459,727 | $20,250,974 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGENX SE
|
Healthcare | 2.23% | 4.29% |
#23
13
Prev: #10
|
0.9 | -15,511 | -40.0% |
P
S
|
23,256 | $19,557,133 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NTRA
NATERA INC
|
Healthcare | 2.12% | 1.95% |
#24
1
Prev: #25
|
1.8 | no change | no change |
P
S
|
80,875 | $18,527,654 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.88% | 3.89% |
#25
13
Prev: #12
|
1.3 | -149,167 | -6.9% |
P
S
|
2,010,307 | $16,444,311 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 1.84% | 2.36% |
#26
5
Prev: #21
|
0.7 | -71,281 | -25.7% |
P
S
|
206,445 | $16,063,485 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.79% | — |
#27
Prev: #—
|
4.2 | 146,303 | no change |
NEW
|
146,303 | $15,660,273 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 1.76% | — |
#28
Prev: #—
|
4.2 | 617,714 | no change |
NEW
|
617,714 | $15,442,850 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 1.54% | — |
#29
Prev: #—
|
4.1 | 565,142 | no change |
NEW
|
565,142 | $13,467,334 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 1.39% | 3.95% |
#30
19
Prev: #11
|
0.6 | -244,487 | -61.5% |
P
S
|
153,206 | $12,166,088 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 1.20% | — |
#31
Prev: #—
|
4.0 | 35,749 | no change |
NEW
|
35,749 | $10,536,660 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.88% | — |
#32
Prev: #—
|
3.9 | 321,655 | no change |
NEW
|
321,655 | $7,697,204 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.40% | 0.28% |
#33
4
Prev: #29
|
1.2 | no change | no change |
P
S
|
262,643 | $3,461,635 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HROW
HARROW INC
|
Healthcare | 0.00% | 1.16% |
Sold All 😨
(Was: #28) |
0.0 | -160,234 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADMA
ADMA BIOLOGICS ...
|
Healthcare | 0.00% | 1.78% |
Sold All 😨
(Was: #26) |
0.0 | -808,673 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 0.00% | 2.35% |
Sold All 😨
(Was: #22) |
0.0 | -639,699 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.00% | 2.41% |
Sold All 😨
(Was: #19) |
0.0 | -783,411 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 2.83% |
Sold All 😨
(Was: #17) |
0.0 | -397,010 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.00% | 3.83% |
Sold All 😨
(Was: #14) |
0.0 | -181,897 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACLX
ARCELLX INC
|
Healthcare | 0.00% | 3.87% |
Sold All 😨
(Was: #13) |
0.0 | -313,733 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRUS
MERUS N V
|
Healthcare | 0.00% | 5.26% |
Sold All 😨
(Was: #4) |
0.0 | -372,022 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-41 of 41 holdings